NEW YORK ─ PathoFinder said this week that it has obtained the CE-IVD mark for its RealAccurate Quadruplex SARS-CoV-2 PCR kit, allowing it to be marketed in the European Union and other countries that recognize the CE mark.
NEW YORK ─ PathoFinder said this week that it has obtained the CE-IVD mark for its RealAccurate Quadruplex SARS-CoV-2 PCR kit, allowing it to be marketed in the European Union and other countries that recognize the CE mark.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.